Language
Germany

Update notification · 14.08.2026

Supply shortage: Pantoprazol-Micro Labs 40 mg magensaftresistente Tabletten

Affected country: Germany · Reported period: 03.07.2026 – 11.09.2026 · Active ingredient: Pantoprazol-Natrium-Sesquihydrat

CountryGermany
PZN10516704, 10516710, 17378458, 18874024
ENR2179977
Notification typeUpdate notification
Start03.07.2026
Expected end11.09.2026
Last update14.08.2026
ReasonOther
ATCA02BC02
Hospital-relevantYes

Notice context

A supply shortage has been recorded for Pantoprazol-Micro Labs 40 mg magensaftresistente Tabletten in Germany. The stated reason is “Other”. The notice concerns the active ingredient Pantoprazol-Natrium-Sesquihydrat and is identified as hospital-relevant.

This information describes the reported supply status and is not medical or pharmaceutical treatment advice. Availability, alternatives and further measures must be assessed for each individual case by the responsible pharmaceutical market participants.

Primary source: PharmNet.Bund / BfArM

Official shortage notice for Germany. Responsibility and update procedures follow the information supplied by the relevant authority.

Check the official notice list →

SEO-relevant topics